Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tempest Therapeutics Q2 EPS $(7.63) Up From $(11.42) YoY

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(7.63) per share. This is a 33.19 percent increase over losses of $(11.42) per share from the same period last year.
byBenzinga Newsdesk
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(7.63) per share. This is a 33.19 percent increase over losses of $(11.42) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0